Cargando…

Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids

AIMS: An intergenic locus on chromosome 1 (lead SNP rs10911021) was previously associated with coronary heart disease (CHD) in type 2 diabetes (T2D). Using data from the UCLEB consortium we investigated the relationship between rs10911021 and CHD in T2D, whether rs10911021 was associated with levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaney, Katherine E., Cooper, Jackie A., McLachlan, Stela, Wannamethee, S. Goya, Jefferis, Barbara J., Whincup, Peter, Ben-Shlomo, Yoav, Price, Jacqueline F., Kumari, Meena, Wong, Andrew, Ong, Ken, Hardy, Rebecca, Kuh, Diana, Kivimaki, Mika, Kangas, Antti J., Soininen, Pasi, Ala-Korpela, Mika, Drenos, Fotios, Humphries, Steve E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994200/
https://www.ncbi.nlm.nih.gov/pubmed/27549350
http://dx.doi.org/10.1186/s12933-016-0435-0
_version_ 1782449278316183552
author Beaney, Katherine E.
Cooper, Jackie A.
McLachlan, Stela
Wannamethee, S. Goya
Jefferis, Barbara J.
Whincup, Peter
Ben-Shlomo, Yoav
Price, Jacqueline F.
Kumari, Meena
Wong, Andrew
Ong, Ken
Hardy, Rebecca
Kuh, Diana
Kivimaki, Mika
Kangas, Antti J.
Soininen, Pasi
Ala-Korpela, Mika
Drenos, Fotios
Humphries, Steve E.
author_facet Beaney, Katherine E.
Cooper, Jackie A.
McLachlan, Stela
Wannamethee, S. Goya
Jefferis, Barbara J.
Whincup, Peter
Ben-Shlomo, Yoav
Price, Jacqueline F.
Kumari, Meena
Wong, Andrew
Ong, Ken
Hardy, Rebecca
Kuh, Diana
Kivimaki, Mika
Kangas, Antti J.
Soininen, Pasi
Ala-Korpela, Mika
Drenos, Fotios
Humphries, Steve E.
author_sort Beaney, Katherine E.
collection PubMed
description AIMS: An intergenic locus on chromosome 1 (lead SNP rs10911021) was previously associated with coronary heart disease (CHD) in type 2 diabetes (T2D). Using data from the UCLEB consortium we investigated the relationship between rs10911021 and CHD in T2D, whether rs10911021 was associated with levels of amino acids involved in the γ-glutamyl cycle or any conventional risk factors (CRFs) for CHD in the T2D participants. METHODS: Four UCLEB studies (n = 6531) had rs10911021 imputation, CHD in T2D, CRF and metabolomics data determined using a nuclear magnetic resonance based platform. RESULTS: The expected direction of effect between rs10911021 and CHD in T2D was observed (1377 no CHD/160 CHD; minor allele OR 0.80, 95 % CI 0.60–1.06) although this was not statistically significant (p = 0.13). No association between rs10911021 and CHD was seen in non-T2D participants (11218 no CHD/1274 CHD; minor allele OR 1.00 95 % CIs 0.92–1.10). In T2D participants, while no associations were observed between rs10911021 and the nine amino acids measured, rs10911021 was associated with HDL-cholesterol (p = 0.0005) but the minor “protective” allele was associated with lower levels (−0.034 mmol/l per allele). Focusing more closely on the HDL-cholesterol subclasses measured, we observed that rs10911021 was associated with six large HDL particle measures in T2D (all p < 0.001). No significant associations were seen in non-T2D subjects. CONCLUSIONS: Our findings are consistent with a true association between rs10911021 and CHD in T2D. The protective minor allele was associated with lower HDL-cholesterol and reductions in HDL particle traits. Our results indicate a complex relationship between rs10911021 and CHD in T2D. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-016-0435-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4994200
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49942002016-08-24 Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids Beaney, Katherine E. Cooper, Jackie A. McLachlan, Stela Wannamethee, S. Goya Jefferis, Barbara J. Whincup, Peter Ben-Shlomo, Yoav Price, Jacqueline F. Kumari, Meena Wong, Andrew Ong, Ken Hardy, Rebecca Kuh, Diana Kivimaki, Mika Kangas, Antti J. Soininen, Pasi Ala-Korpela, Mika Drenos, Fotios Humphries, Steve E. Cardiovasc Diabetol Original Investigation AIMS: An intergenic locus on chromosome 1 (lead SNP rs10911021) was previously associated with coronary heart disease (CHD) in type 2 diabetes (T2D). Using data from the UCLEB consortium we investigated the relationship between rs10911021 and CHD in T2D, whether rs10911021 was associated with levels of amino acids involved in the γ-glutamyl cycle or any conventional risk factors (CRFs) for CHD in the T2D participants. METHODS: Four UCLEB studies (n = 6531) had rs10911021 imputation, CHD in T2D, CRF and metabolomics data determined using a nuclear magnetic resonance based platform. RESULTS: The expected direction of effect between rs10911021 and CHD in T2D was observed (1377 no CHD/160 CHD; minor allele OR 0.80, 95 % CI 0.60–1.06) although this was not statistically significant (p = 0.13). No association between rs10911021 and CHD was seen in non-T2D participants (11218 no CHD/1274 CHD; minor allele OR 1.00 95 % CIs 0.92–1.10). In T2D participants, while no associations were observed between rs10911021 and the nine amino acids measured, rs10911021 was associated with HDL-cholesterol (p = 0.0005) but the minor “protective” allele was associated with lower levels (−0.034 mmol/l per allele). Focusing more closely on the HDL-cholesterol subclasses measured, we observed that rs10911021 was associated with six large HDL particle measures in T2D (all p < 0.001). No significant associations were seen in non-T2D subjects. CONCLUSIONS: Our findings are consistent with a true association between rs10911021 and CHD in T2D. The protective minor allele was associated with lower HDL-cholesterol and reductions in HDL particle traits. Our results indicate a complex relationship between rs10911021 and CHD in T2D. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-016-0435-0) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-22 /pmc/articles/PMC4994200/ /pubmed/27549350 http://dx.doi.org/10.1186/s12933-016-0435-0 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Beaney, Katherine E.
Cooper, Jackie A.
McLachlan, Stela
Wannamethee, S. Goya
Jefferis, Barbara J.
Whincup, Peter
Ben-Shlomo, Yoav
Price, Jacqueline F.
Kumari, Meena
Wong, Andrew
Ong, Ken
Hardy, Rebecca
Kuh, Diana
Kivimaki, Mika
Kangas, Antti J.
Soininen, Pasi
Ala-Korpela, Mika
Drenos, Fotios
Humphries, Steve E.
Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids
title Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids
title_full Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids
title_fullStr Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids
title_full_unstemmed Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids
title_short Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids
title_sort variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating hdl cholesterol and large hdl particles but not with amino acids
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994200/
https://www.ncbi.nlm.nih.gov/pubmed/27549350
http://dx.doi.org/10.1186/s12933-016-0435-0
work_keys_str_mv AT beaneykatherinee variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT cooperjackiea variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT mclachlanstela variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT wannametheesgoya variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT jefferisbarbaraj variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT whincuppeter variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT benshlomoyoav variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT pricejacquelinef variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT kumarimeena variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT wongandrew variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT ongken variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT hardyrebecca variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT kuhdiana variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT kivimakimika variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT kangasanttij variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT soininenpasi variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT alakorpelamika variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT drenosfotios variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT humphriesstevee variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids
AT variantrs10911021thatassociateswithcoronaryheartdiseaseintype2diabetesisassociatedwithlowerconcentrationsofcirculatinghdlcholesterolandlargehdlparticlesbutnotwithaminoacids